Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

Biotech's twentieth birthday blues

Nature Reviews Drug Discovery volume 2, pages 231–233 (2003)Cite this article

Suggestions that the FDA is the main obstacle to creating new drugs are widespread and have the effect of diverting attention from more significant problems facing the biotech industry. These include counterproductive management and organizational trends, as well as a crisis in biomedical research.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Miller, H. I. As biotech turns 20... Nature Rev. Drug Discov. 2, 1007–1008 (2002).

    Article  Google Scholar 

  2. Mises, L. Bureaucracy (Libertarian, Spring Mills, Pennsylvania, 1996).

    Google Scholar 

  3. Fernandes, M. & Miska, D. The role of governance in drug development. Scrip Magazine, pp10–11 (November 2002).

  4. Watson, J. D. & Crick, F. H. C. A structure for deoxyribose nucleic acid. Nature 171, 737–738 (1953).

    Article  CAS  Google Scholar 

  5. Henderson, R. & Cockburn, I. Firm size and research productivity in drug disvovery. [online] (cited 12 Jan 03) <http://www.mit.edu/afs/athena/course/15/15.141/readings/insee97.pdf> (Jan 1997).

  6. Horrobin, D. F. Commercialization of biotechnology: might Cassandra be right? Presented at 53rd Mosbach Kolloquium, Mosbach, Baden (April 2002).

  7. Demain, A. L. Prescription for an ailing pharmaceutical industry. Nature Biotechnol. 20, 331 (2002).

    Article  Google Scholar 

  8. Le Fanu, J. The Rise and Fall of Modern Medicine (Carroll & Graff, New York, 1999).

    Book  Google Scholar 

  9. Lewontin, R. The Triple Helix: Gene, Organism, and Environment (Harvard University Press, Cambridge, Massachussetts, 2000).

    Google Scholar 

  10. Gold, T. New ideas in science. J. Sci. Explor. 3, 103–112 (1989).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Senior Partner at Medbase LLC, 94 Gallup Road, Princeton, 08540, New Jersey, USA

    David Miska

Authors
  1. David Miska
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

FURTHER INFORMATION

Encyclopedia of Life Sciences

Daniel Bovet

George Herbert Hitchings

Gertrude Belle Elion

History of biotechnology

James Whyte Black

Ludwig von Mises Institute

US FDA Food and Drug Modernization Act

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miska, D. Biotech's twentieth birthday blues. Nat Rev Drug Discov 2, 231–233 (2003). https://doi.org/10.1038/nrd1036

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd1036

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing